Alliance For Biopharmaceutical Competitiveness And Innovation
Lobbying group · Jul 2025 – Sep 2026
Alliance For Biopharmaceutical Competitiveness And Innovation spent $1.1M lobbying the federal government (Jul 2025 – Sep 2026), mostly on taxes. It used 3 lobbyists, including people who worked for 1 members of Congress.
- Spent on lobbying
- $1.1M
- Lobbyists
- 3
- Bills lobbied
- 11
- Issues
- 1
Spending by quarter
- 2025 Q3$450K
- 2025 Q4$70K
- 2026 Q1$500K
- 2026 Q2$50K
Issues lobbied
- Taxes
Bills lobbied on
- H.R. 13472 reports
- H.R. 1990: American Innovation and R&D Competitiveness Act of 20252 reports
- S. 1872 reports
- S. 5592 reports
- S. 20212 reports
- H.R. 5742 reports
- H.R. 10622 reports
- H.R. 1: One Big Beautiful Bill Act2 reports
- S. 16882 reports
- S. 16392 reports
- S. 16052 reports
Lobbying firms hired
Lobbyists who worked in Congress
- James Pedrotti
Legislative Correspondent, Legislative Assistant, Senior Legislative Assistant, Legislative Director, Deputy Chief of…Carol D. Miller (R-WV)
Agencies contacted
- House Of Representatives · 4
- Senate · 4
- Treasury, Dept of · 1
Related
Filings
- 2026 Q2 report$50K
- 2026 Q1 report$500K
- 2025 Q4 report$70K
- 2025 Q3 report$450K
From Lobbying Disclosure Act reports filed with the Senate and House.
Cite or embed this page
Capitol Receipts, “Alliance For Biopharmaceutical Competitiveness And Innovation…,” https://www.capitolreceipts.com/lobbying/callianceforbiopharmaceuticalcompetitivenessandinnovation/alliance-for-biopharmaceutical-competitiveness-and-innovation (accessed 2026-10-17).